Back
Immunome, Inc. Stock Predictions
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
43
IMNM
Immunome, Inc.
Last Price:
$20.09
Seasonality Move:
57.07%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiImmunome, Inc. Stock Forecast
-
Over the next 52 weeks, Immunome, Inc. has on average historically risen by 34.2% based on the past 5 years of stock performance.
-
Immunome, Inc. has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
-
Is Immunome, Inc. Stock Undervalued?The current Immunome, Inc. [IMNM] share price is $19.37. The Score for IMNM is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
IMNM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Immunome, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Immunome, Inc. has on average historically risen by 34.2% based on the past 5 years of stock performance.
Immunome, Inc. Stock Rating
Sell
43
Immunome, Inc. (IMNM)
is a Sell
Is Immunome, Inc. overpriced?
-
Immunome, Inc. has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Immunome, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunome.com
52-Week Data
52-Week High:
19.66
52-Week Low:
5.15
Prediction Charts
Market Cap:
1.8B
Price in USD:
19.37
Volume:
2.1M
Beta:
1.96
Technical Analysis
SMA50:
15.64
SMA100:
12.84
SMA200:
10.62
52-Wk Change:
43.06%
Stock Predictions
-
Is Immunome, Inc. stock public?Yes, Immunome, Inc. is a publicly traded company.
-
What is the Immunome, Inc. stock quote today?The Immunome, Inc. stock price is 19.37 USD today.
-
How to buy Immunome, Inc. stock online?You can buy Immunome, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-13 | 17.55 | 16.51 | 17.55 | 16.51 |
| Nov-14 | 16.11 | 17.14 | 18.46 | 16.11 |
| Nov-17 | 17.71 | 18.13 | 18.79 | 17.35 |
| Nov-18 | 18.04 | 17.86 | 18.28 | 17.47 |
| Nov-19 | 18.00 | 17.69 | 18.41 | 17.62 |
| Nov-20 | 18.00 | 17.51 | 18.94 | 17.50 |
| Nov-21 | 17.46 | 18.53 | 19.01 | 17.30 |
| Nov-24 | 18.67 | 18.65 | 19.16 | 18.34 |
| Nov-25 | 18.86 | 18.30 | 19.13 | 17.96 |
| Nov-26 | 18.29 | 18.63 | 18.76 | 18.00 |
| Nov-28 | 18.75 | 18.42 | 18.96 | 18.23 |
| Dec-1 | 18.51 | 18.32 | 18.61 | 17.84 |
| Dec-2 | 18.44 | 17.09 | 18.57 | 16.81 |
| Dec-3 | 17.40 | 19.37 | 19.66 | 17.00 |
Immunome, Inc. Earnings
Immunome, Inc. Earnings Report: Per Share Immunome, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Immunome, Inc. Forecast Revenue Growth
Immunome, Inc. Stock Analysis: Historical quarterly revenues per share for Immunome, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.92 per share, and a decrease next year of $0.35 per share.
* Immunome, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.